News Oxford BioDynamics Plc

Equities

OBD

GB00BD5H8572

Delayed London S.E. Other stock markets 07:19:34 2024-04-18 am EDT			5-day change	1st Jan Change
8.85 ^GBX	-0.56%		+1.49%	-68.39%

Apr. 03	Oxford BioDynamics reaches "important milestone" with new laboratory	AN
Apr. 03	Oxford BioDynamics Plc Opens Clinical Testing Facility in the UK to Perform EpiSwitch Prostate Screening Blood Test	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Oxford BioDynamics reaches "important milestone" with new laboratory	Apr. 03	AN
Oxford BioDynamics Plc Opens Clinical Testing Facility in the UK to Perform EpiSwitch Prostate Screening Blood Test	Apr. 03	CI
Oxford Biodynamics Raises GBP9.9 Million to Support EpiSwitch Product Line	Mar. 14	MT
FireAngel CFO resigns; ECR Minerals raises GBP585,000	Mar. 14	AN
EARNINGS AND TRADING: PensionBee nears profit; OptiBiotix Indian deal	Mar. 13	AN
Oxford BioDynamics plunges as annual loss widens; revenue up	Jan. 17	AN
Oxford BioDynamics plunge as annual profit rises; revenue up	Jan. 17	AN
Oxford BioDynamics shares plunge as annual revenue widens; revenue up	Jan. 17	AN
AIM WINNERS & LOSERS: James Cropper falls on lower outlook	Jan. 17	AN
Earnings Flash (OBD.L) OXFORD BIODYNAMICS Reports FY23 Revenue GBP510,000	Jan. 17	MT
Earnings Flash (OBD.L) OXFORD BIODYNAMICS Reports FY23 Loss GBX-7.30	Jan. 17	MT
Oxford BioDynamics Plc Reports Earnings Results for the Full Year Ended September 30, 2023	Jan. 17	CI
Oxford BioDynamics Appoints Steven Arrivo as Senior Vice President of Business and Corporate Development	Nov. 08	CI
FTSE 100 Edged Lower, Buoyed by Resilient Retail Sector	Nov. 07	DJ
Oxford BioDynamics director sells over 700,000 shares	23-10-20	AN
Oxford BioDynamics Plc - Bupa UK to cover EpiSwitch CiRT for customers with cancer	23-10-19	AQ
Oxford BioDynamics Strikes Deal with Bupa for Access to Blood Test	23-10-18	MT
Bupa UK to cover EpiSwitch® CiRT for customers with cancer	23-10-18	BU
Oxford BioDynamics in deal with Bupa to expand blood test access	23-10-18	AN
Oxford BioDynamics, Plc Announces a Strategic Agreement to Give Bupa Patients Access to OBD'sEpiSwitch CiRT	23-10-18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Oxford BioDynamics Plc

Equities

OBD

GB00BD5H8572

Summary

Filters